United States Transdermal Drug Patches Market Report 2016

October 2016 | 124 pages | ID: UADEBC63431EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Transdermal Drug Patches

Revenue, means the sales value of Transdermal Drug Patches

This report studies sales (consumption) of Transdermal Drug Patches in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Boehringer Ingelheim
• Janssen Pharmaceutica
• GlaxoSmithKline
• Mylan
• Noven
• Bayer
• Actavis
• Echo Therapeutics
• Teva Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Single-layer Drug-in-Adhesive
• Multi-layer Drug-in-Adhesive
• Reservoir
• Matrix
• Vapour Patch

Split by applications, this report focuses on sales, market share and growth rate of Transdermal Drug Patches in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Transdermal Drug Patches Market Report 2016

1 TRANSDERMAL DRUG PATCHES OVERVIEW

1.1 Product Overview and Scope of Transdermal Drug Patches
1.2 Classification of Transdermal Drug Patches
  1.2.1 Single-layer Drug-in-Adhesive
  1.2.2 Multi-layer Drug-in-Adhesive
  1.2.3 Reservoir
  1.2.4 Matrix
  1.2.5 Vapour Patch
1.3 Application of Transdermal Drug Patches
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Transdermal Drug Patches (2011-2021)
  1.4.1 USA Transdermal Drug Patches Sales and Growth Rate (2011-2021)
  1.4.2 USA Transdermal Drug Patches Revenue and Growth Rate (2011-2021)

2 USA TRANSDERMAL DRUG PATCHES COMPETITION BY MANUFACTURERS

2.1 USA Transdermal Drug Patches Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Transdermal Drug Patches Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Transdermal Drug Patches Average Price by Manufactures (2015 and 2016)
2.4 Transdermal Drug Patches Market Competitive Situation and Trends
  2.4.1 Transdermal Drug Patches Market Concentration Rate
  2.4.2 Transdermal Drug Patches Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA TRANSDERMAL DRUG PATCHES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Transdermal Drug Patches Sales and Market Share by Type (2011-2016)
3.2 USA Transdermal Drug Patches Revenue and Market Share by Type (2011-2016)
3.3 USA Transdermal Drug Patches Price by Type (2011-2016)
3.4 USA Transdermal Drug Patches Sales Growth Rate by Type (2011-2016)

4 USA TRANSDERMAL DRUG PATCHES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Transdermal Drug Patches Sales and Market Share by Application (2011-2016)
4.2 USA Transdermal Drug Patches Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA TRANSDERMAL DRUG PATCHES MANUFACTURERS PROFILES/ANALYSIS

5.1 Boehringer Ingelheim
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Transdermal Drug Patches Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Boehringer Ingelheim Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Janssen Pharmaceutica
  5.2.2 Transdermal Drug Patches Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Janssen Pharmaceutica Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline
  5.3.2 Transdermal Drug Patches Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Mylan
  5.4.2 Transdermal Drug Patches Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Noven
  5.5.2 Transdermal Drug Patches Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Bayer
  5.6.2 Transdermal Drug Patches Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Bayer Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Actavis
  5.7.2 Transdermal Drug Patches Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Actavis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Echo Therapeutics
  5.8.2 Transdermal Drug Patches Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Echo Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Teva Pharmaceuticals
  5.9.2 Transdermal Drug Patches Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Teva Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 TRANSDERMAL DRUG PATCHES MANUFACTURING COST ANALYSIS

6.1 Transdermal Drug Patches Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Transdermal Drug Patches

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Transdermal Drug Patches Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Transdermal Drug Patches Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA TRANSDERMAL DRUG PATCHES MARKET FORECAST (2016-2021)

10.1 USA Transdermal Drug Patches Sales, Revenue Forecast (2016-2021)
10.2 USA Transdermal Drug Patches Sales Forecast by Type (2016-2021)
10.3 USA Transdermal Drug Patches Sales Forecast by Application (2016-2021)
10.4 Transdermal Drug Patches Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Transdermal Drug Patches
Table Classification of Transdermal Drug Patches
Figure USA Sales Market Share of Transdermal Drug Patches by Type in 2015
Figure Single-layer Drug-in-Adhesive Picture
Figure Multi-layer Drug-in-Adhesive Picture
Figure Reservoir Picture
Figure Matrix Picture
Figure Vapour Patch Picture
Table Application of Transdermal Drug Patches
Figure USA Sales Market Share of Transdermal Drug Patches by Application in 2015
Figure USA Transdermal Drug Patches Sales and Growth Rate (2011-2021)
Figure USA Transdermal Drug Patches Revenue and Growth Rate (2011-2021)
Table USA Transdermal Drug Patches Sales of Key Manufacturers (2015 and 2016)
Table USA Transdermal Drug Patches Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Transdermal Drug Patches Sales Share by Manufacturers
Figure 2016 Transdermal Drug Patches Sales Share by Manufacturers
Table USA Transdermal Drug Patches Revenue by Manufacturers (2015 and 2016)
Table USA Transdermal Drug Patches Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Transdermal Drug Patches Revenue Share by Manufacturers
Table 2016 USA Transdermal Drug Patches Revenue Share by Manufacturers
Table USA Market Transdermal Drug Patches Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Transdermal Drug Patches Average Price of Key Manufacturers in 2015
Figure Transdermal Drug Patches Market Share of Top 3 Manufacturers
Figure Transdermal Drug Patches Market Share of Top 5 Manufacturers
Table USA Transdermal Drug Patches Sales by Type (2011-2016)
Table USA Transdermal Drug Patches Sales Share by Type (2011-2016)
Figure USA Transdermal Drug Patches Sales Market Share by Type in 2015
Table USA Transdermal Drug Patches Revenue and Market Share by Type (2011-2016)
Table USA Transdermal Drug Patches Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Transdermal Drug Patches by Type (2011-2016)
Table USA Transdermal Drug Patches Price by Type (2011-2016)
Figure USA Transdermal Drug Patches Sales Growth Rate by Type (2011-2016)
Table USA Transdermal Drug Patches Sales by Application (2011-2016)
Table USA Transdermal Drug Patches Sales Market Share by Application (2011-2016)
Figure USA Transdermal Drug Patches Sales Market Share by Application in 2015
Table USA Transdermal Drug Patches Sales Growth Rate by Application (2011-2016)
Figure USA Transdermal Drug Patches Sales Growth Rate by Application (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Transdermal Drug Patches Sales Market Share (2011-2016)
Table Janssen Pharmaceutica Basic Information List
Table Janssen Pharmaceutica Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceutica Transdermal Drug Patches Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Transdermal Drug Patches Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Transdermal Drug Patches Sales Market Share (2011-2016)
Table Noven Basic Information List
Table Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Table Noven Transdermal Drug Patches Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Transdermal Drug Patches Sales Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actavis Transdermal Drug Patches Sales Market Share (2011-2016)
Table Echo Therapeutics Basic Information List
Table Echo Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Table Echo Therapeutics Transdermal Drug Patches Sales Market Share (2011-2016)
Table Teva Pharmaceuticals Basic Information List
Table Teva Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceuticals Transdermal Drug Patches Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Drug Patches
Figure Manufacturing Process Analysis of Transdermal Drug Patches
Figure Transdermal Drug Patches Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Drug Patches Major Manufacturers in 2015
Table Major Buyers of Transdermal Drug Patches
Table Distributors/Traders List
Figure USA Transdermal Drug Patches Production and Growth Rate Forecast (2016-2021)
Figure USA Transdermal Drug Patches Revenue and Growth Rate Forecast (2016-2021)
Table USA Transdermal Drug Patches Production Forecast by Type (2016-2021)
Table USA Transdermal Drug Patches Consumption Forecast by Application (2016-2021)